Clinical trials recruiting in Belmont, Massachusetts

Phase breakdown

Conditions recruiting in Belmont, Massachusetts

Recruiting trials in Belmont, Massachusetts

• A Study of Brenipatide in Adult Participants With Schizophrenia
  NCT07410507 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female)
• A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
  NCT06585787 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female)
• Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
  NCT05457465 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
  NCT07728695 · Phase: Phase 1, Phase 2 · Ages: 21 Years and older · Sex: Female
• Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
  NCT05630963 · Phase: Not specified · Ages: 18 Years to 45 Years · Sex: All (male and female)
• Biomarkers to Enhance Early Schizophrenia Treatment
  NCT06969755 · Phase: Phase 4 · Ages: 18 Years to 35 Years · Sex: All (male and female)
• Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
  NCT06740383 · Phase: Not specified · Ages: 18 Years to 40 Years · Sex: All (male and female)
• Cerebellar Modulation of Cognition in Psychosis
  NCT06107764 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: All (male and female)
• Cerebellar TMS and Satiety in Prader-Willi Syndrome
  NCT05938543 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: All (male and female)
• Early Life Stress and Depression: Molecular and Functional Imaging
  NCT04713722 · Phase: Not specified · Ages: 20 Years to 32 Years · Sex: Female
• Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
  NCT05837104 · Phase: Phase 2 · Ages: 18 Years to 50 Years · Sex: All (male and female)
• Enhanced Coordinated Specialty Care for Early Psychosis
  NCT06071858 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female)
• Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis
  NCT06477406 · Phase: Phase 2 · Ages: 21 Years and older · Sex: Female
• Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
  NCT07101094 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Individually Targeted Neuromodulation for Contamination-based OCD
  NCT05048251 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: All (male and female)
• Interpretation Bias as a Mechanism of Treatment Response in OCD
  NCT05224414 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
  NCT06221852 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female)
• Mechanisms of Exposure Therapy for OCD
  NCT06173752 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female)
• MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
  NCT06191965 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 35 Years · Sex: All (male and female)
• Neural Correlates of Stress and Perceived Control in Adolescent Depression
  NCT04788524 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 18 Years · Sex: Female
• One-Day cTBS Over the Precuneus
  NCT07758010 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
  NCT05980949 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female)
• Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
  NCT05245903 · Phase: Not specified · Ages: 18 Years to 89 Years · Sex: All (male and female)
• Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation
  NCT05232032 · Phase: Phase 2 · Ages: 18 Years to 45 Years · Sex: All (male and female)
• Pharmacologic Augmentation of TMS for Depression With D-serine
  NCT06876129 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Role of Parent Interpretation Bias in the Transmission of Anxiety to Children
  NCT05665491 · Phase: Not applicable (e.g. observational or device study) · Ages: 7 Years and older · Sex: All (male and female)
• Stress Dynamics and Familial Risk for Depression in Female Adolescents
  NCT06816329 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 15 Years · Sex: Female
• Study of ALTO-101 in Patients With Schizophrenia
  NCT06502964 · Phase: Phase 2 · Ages: 21 Years to 55 Years · Sex: All (male and female)
• Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression
  NCT07560878 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female)
• Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
  NCT06373016 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female)
• Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia
  NCT05343598 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: All (male and female)
• Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans
  NCT06105164 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Belmont, Massachusetts?

32 recruiting trials have at least one study site in Belmont, Massachusetts.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.